{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:19:10Z","timestamp":1774264750251,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI089859"],"award-info":[{"award-number":["U01AI089859"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["N01AI40065"],"award-info":[{"award-number":["N01AI40065"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37AI048793"],"award-info":[{"award-number":["R37AI048793"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI033144"],"award-info":[{"award-number":["R01AI033144"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.coviro.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T01:51:47Z","timestamp":1459389107000},"page":"116-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Vaccinology in the third millennium: scientific and social challenges"],"prefix":"10.1016","volume":"17","author":[{"given":"Gregory A","family":"Poland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline M","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna G","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2016.03.003_bib0560","first-page":"621","article-title":"Centers for Disease Control and Prevention","volume":"48","year":"1999","journal-title":"MMWR"},{"key":"10.1016\/j.coviro.2016.03.003_bib0565","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2016.03.003_bib0570","series-title":"HIV\/AIDS Fact Sheet No. 360","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.coviro.2016.03.003_bib0575","series-title":"Ebola Situation Report","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.coviro.2016.03.003_bib0580","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2016.03.003_bib0585","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.03.003_bib0590","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/infdis\/jiu511","article-title":"Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial","volume":"211","author":"Sarwar","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0595","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(14)62385-0","article-title":"Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial","volume":"385","author":"Kibuuka","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2016.03.003_bib0600","first-page":"h3740","article-title":"The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola","volume":"351","author":"E\u00e7SRVT Consortium","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0605","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMp1506820","article-title":"Establishing a global vaccine-development fund","volume":"373","author":"Plotkin","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.03.003_bib0610","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/589722","article-title":"Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine","volume":"198","author":"Cardell","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0615","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1086\/524146","article-title":"Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?","volume":"197","author":"Skowronski","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0620","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0625","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","article-title":"Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0630","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.clpt.6100415","article-title":"Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics","volume":"82","author":"Poland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coviro.2016.03.003_bib0635","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14760584.5.1.33","article-title":"Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines","volume":"5","author":"Ovsyannikova","year":"2006","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.coviro.2016.03.003_bib0640","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1016\/j.vaccine.2012.07.063","article-title":"Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique","volume":"30","author":"Clifford","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0645","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/338014","article-title":"Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine","volume":"185","author":"Gelder","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0650","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/gene.2010.1","article-title":"New genetic associations detected in a host response study to hepatitis B vaccine","volume":"11","author":"Davila","year":"2010","journal-title":"Genes Immunity"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0655","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/cid\/cit934","article-title":"The pertussis problem","volume":"58","author":"Plotkin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0660","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1471-2334-13-151","article-title":"Pertussis re-emergence in the post-vaccination era","volume":"13","author":"Chiappini","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0665","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0670","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.03.003_bib0675","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/infdis\/jit365","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age","volume":"208","author":"Chlibek","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0680","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2014.01.019","article-title":"Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study","volume":"32","author":"Chlibek","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0685","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.03.003_bib0690","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1073\/pnas.0903181106","article-title":"Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.03.003_bib0695","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.vaccine.2008.01.019","article-title":"Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses","volume":"26","author":"Ansaldi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0700","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1016\/j.vaccine.2014.07.013","article-title":"Comparison of the safety and immunogenicity of an MF59(R)-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects","volume":"32","author":"Frey","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0705","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.03.003_bib0710","doi-asserted-by":"crossref","first-page":"e108489","DOI":"10.1371\/journal.pone.0108489","article-title":"Risk of narcolepsy associated with inactivated adjuvanted (AS03) A\/H1N1 (2009) pandemic influenza vaccine in Quebec","volume":"9","author":"Montplaisir","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2016.03.003_bib0715","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.smim.2013.04.007","article-title":"Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century","volume":"25","author":"Poland","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0720","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00006454-199601000-00014","article-title":"Secondary failure rates of measles vaccines: a metaanalysis of published studies","volume":"15","author":"Anders","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.coviro.2016.03.003_bib0725","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jama.1997.03540380070034","article-title":"Measles re-immunization in children seronegative after initial immunization","volume":"277","author":"Poland","year":"1997","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.coviro.2016.03.003_bib0730","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/003655499750006272","article-title":"Intradermal hepatitis B vaccination in health care workers. Response rate and experiences from vaccination in clinical practise","volume":"31","author":"Cardell","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.coviro.2016.03.003_bib0735","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM198909143211103","article-title":"Genetic prediction of nonresponse to hepatitis B vaccine","volume":"321","author":"Alper","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.03.003_bib0740","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2004.02.025","article-title":"Immunogenicity and protective efficacy of influenza vaccination","volume":"103","author":"Hannoun","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2016.03.003_bib0745","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.1980.03300500016019","article-title":"Guillain\u2013Barre syndrome in recipients of A\/New Jersey influenza vaccine","volume":"243","author":"Marks","year":"1980","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.coviro.2016.03.003_bib0750","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain\u2013Barre syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.coviro.2016.03.003_bib0755","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0760","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coviro.2016.03.003_bib0765","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coviro.2016.03.003_bib0770","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3109\/02770903.2013.834505","article-title":"Asthma and severity of 2009 novel H1N1 influenza: a population-based case\u2013control study","volume":"50","author":"Santillan Salas","year":"2013","journal-title":"J Asthma"},{"key":"10.1016\/j.coviro.2016.03.003_bib0775","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2012.11.095","article-title":"Investigation of an outbreak of hypersensitivity-type reactions during the 2004 national measles-mumps-rubella vaccination campaign in Brazil","volume":"31","author":"Freitas","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0780","first-page":"244","article-title":"Age-related risk of adverse events following yellow fever vaccination in Australia","volume":"28","author":"Lawrence","year":"2004","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.coviro.2016.03.003_bib0785","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0976-500X.92514","article-title":"Diphtheria, pertussis (whooping cough), and tetanus vaccine induced recurrent seizures and acute encephalopathy in a pediatric patient: possibly due to pertussis fraction","volume":"3","author":"Patel","year":"2012","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.coviro.2016.03.003_bib0790","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa003077","article-title":"The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine","volume":"345","author":"Barlow","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.03.003_bib0795","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s10156-010-0065-5","article-title":"Vaccine-associated paralytic poliomyelitis in an infant with perianal abscesses","volume":"16","author":"Higashigawa","year":"2010","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.coviro.2016.03.003_bib0800","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/INF.0b013e3181a6a511","article-title":"Adversomics: the emerging field of vaccine adverse event immunogenetics","volume":"28","author":"Poland","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0805","first-page":"1","article-title":"Adversomics: a new paradigm for vaccine safety and design","author":"Whitaker","year":"2015","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.coviro.2016.03.003_bib0810","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.it.2009.05.002","article-title":"Vaccination in the elderly: an immunological perspective","volume":"30","author":"Chen","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0815","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0889-8561(02)00055-3","article-title":"Problems and solutions to the development of vaccines in the elderly","volume":"23","author":"Effros","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.coviro.2016.03.003_bib0820","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03324904","article-title":"Immunosenescence and vaccine failure in the elderly","volume":"21","author":"Grubeck-Loebenstein","year":"2009","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0825","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2014.11.022","article-title":"The need for a multi-disciplinary perspective on vaccine hesitancy and acceptance","volume":"33","author":"Poland","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0830","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1016\/j.vaccine.2011.07.131","article-title":"Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education","volume":"29","author":"Poland","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0835","series-title":"The Wiley-Blackwell Encyclopedia of Health, Illness, Behavior and Society","article-title":"Vaccination as a public health measure: challenges","author":"Poland","year":"2014"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0840","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ni.2871","article-title":"Toward a human vaccines project","volume":"15","author":"Koff","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0845","doi-asserted-by":"crossref","first-page":"1232910","DOI":"10.1126\/science.1232910","article-title":"Accelerating next-generation vaccine development for global disease prevention","volume":"340","author":"Koff","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.03.003_bib0850","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/14760584.2015.1013466","article-title":"Building the Human Vaccines Project: strategic management recommendations and summary report of the 15\u201316 July 2014 business workshop","volume":"14","author":"Schenkelberg","year":"2015","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.coviro.2016.03.003_bib0855","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/eji.201343751","article-title":"The who's who of T-cell differentiation: human memory T-cell subsets","volume":"43","author":"Mahnke","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0860","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3389\/fimmu.2014.00630","article-title":"Plasticity of human CD4 T cell subsets","volume":"5","author":"Geginat","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0865","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2015.00129","article-title":"The known unknowns of the human dendritic cell network","volume":"6","author":"Durand","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0870","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0875","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0880","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0885","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.03.003_bib0890","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.it.2014.07.003","article-title":"Influence of the microbiota on vaccine effectiveness","volume":"35","author":"Valdez","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0895","doi-asserted-by":"crossref","first-page":"12300","DOI":"10.1073\/pnas.1400476111","article-title":"Systems vaccinology: probing humanity's diverse immune systems with vaccines","volume":"111","author":"Pulendran","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.03.003_bib0900","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.immuni.2012.12.008","article-title":"Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines","volume":"38","author":"Obermoser","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0905","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.coi.2011.04.005","article-title":"Systems biology approaches to new vaccine development","volume":"23","author":"Oberg","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0910","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.molcel.2015.05.004","article-title":"High-throughput sequencing technologies","volume":"58","author":"Reuter","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.coviro.2016.03.003_bib0915","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.molcel.2015.05.005","article-title":"Advances and applications of single-cell sequencing technologies","volume":"58","author":"Wang","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.coviro.2016.03.003_bib0920","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.it.2012.02.010","article-title":"A deep profiler's guide to cytometry","volume":"33","author":"Bendall","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2010.07.002","article-title":"Highly multiparametric analysis by mass cytometry","volume":"361","author":"Ornatsky","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.coviro.2016.03.003_bib0930","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.coi.2013.07.004","article-title":"Single-cell mass cytometry for analysis of immune system functional states","volume":"25","author":"Bjornson","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.04.088","article-title":"Lessons learned in the analysis of high-dimensional data in vaccinomics","author":"Oberg","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0940","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0146","article-title":"Vaccinology in the era of high-throughput biology","volume":"370","author":"Nakaya","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.coviro.2016.03.003_bib0945","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1146\/annurev-immunol-032713-120254","article-title":"Systems-level analysis of innate immunity","volume":"32","author":"Zak","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_sbref0950","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev-immunol-030409-101317","article-title":"Systems biology in immunology: a computational modeling perspective","volume":"29","author":"Germain","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0955","doi-asserted-by":"crossref","first-page":"904541","DOI":"10.1155\/2015\/904541","article-title":"Trends in IT innovation to build a next generation bioinformatics solution to manage and analyse biological big data produced by NGS technologies","volume":"2015","author":"de Brevern","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.coviro.2016.03.003_bib0960","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.ppat.1002344","article-title":"Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?","volume":"7","author":"Poland","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.03.003_bib0965","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/omi.2011.0012","article-title":"The top five \u201cgame changers\u201d in vaccinology: toward rational and directed vaccine development","volume":"15","author":"Kennedy","year":"2011","journal-title":"OMICS"},{"key":"10.1016\/j.coviro.2016.03.003_bib0970","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/omi.2011.0032","article-title":"Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections","volume":"15","author":"Poland","year":"2011","journal-title":"OMICS"},{"key":"10.1016\/j.coviro.2016.03.003_bib0975","first-page":"438","article-title":"Vaccinomics: current findings, challenges and novel approaches for vaccine development","volume":"13","author":"Ovsyannikova","year":"2011","journal-title":"Am Assoc Pharm Sci"},{"key":"10.1016\/j.coviro.2016.03.003_bib0980","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2217\/fmb.10.146","article-title":"Vaccinomics, predictive vaccinology and the future of vaccine development","volume":"5","author":"Haralambieva","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.coviro.2016.03.003_bib0985","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/j.vaccine.2010.03.031","article-title":"Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology","volume":"28","author":"Poland","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0990","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/j.vaccine.2009.01.069","article-title":"Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine and consumer culture and vaccinomics","volume":"27","author":"Poland","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib0995","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1517\/14712598.8.11.1659","article-title":"Personalized vaccines: the emerging field of vaccinomics","volume":"8","author":"Poland","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.coviro.2016.03.003_sbref1000","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.it.2015.06.005","article-title":"Utilizing population variation, vaccination, and systems biology to study human immunology","volume":"36","author":"Tsang","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib1005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phrs.2014.08.006","article-title":"Computational modelling approaches to vaccinology","volume":"92","author":"Pappalardo","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.coviro.2016.03.003_bib1010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.coi.2013.09.014","article-title":"A systems framework for vaccine design","volume":"25","author":"Mooney","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib1015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.smim.2012.11.002","article-title":"Recent progress using systems biology approaches to better understand molecular mechanisms of immunity","volume":"25","author":"Gottschalk","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib1020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.immuni.2012.10.014","article-title":"Innate immune function by toll-like receptors: distinct responses in newborns and the elderly","volume":"37","author":"Kollmann","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2016.03.003_bib1025","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.vaccine.2012.10.016","article-title":"Immune response to vaccine adjuvants during the first year of life","volume":"31","author":"Levy","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.03.003_bib1030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.imlet.2014.06.006","article-title":"Immunosenescence and vaccine failure in the elderly: strategies for improving response","volume":"162","author":"Boraschi","year":"2014","journal-title":"Immunol Lett"},{"key":"10.1016\/j.coviro.2016.03.003_sbref1035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.coi.2014.04.005","article-title":"A systems biology approach to the effect of aging, immunosenescence and vaccine response","volume":"29C","author":"Poland","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib1040","first-page":"117","article-title":"Systems biology of vaccination in the elderly","volume":"363","author":"Duraisingham","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2016.03.003_bib1045","doi-asserted-by":"crossref","first-page":"e0133627","DOI":"10.1371\/journal.pone.0133627","article-title":"Large-scale and comprehensive immune profiling and functional analysis of normal human aging","volume":"10","author":"Whiting","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2016.03.003_bib1050","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1038\/ncomms6283","article-title":"Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines","volume":"5","author":"Banchereau","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2016.03.003_bib1055","series-title":"Fact sheet 2015","author":"UNAIDS","year":"2016"},{"key":"10.1016\/j.coviro.2016.03.003_bib1060","series-title":"Global Tuberculosis Report 2015","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.coviro.2016.03.003_bib1065","series-title":"Malaria Fact Sheet","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.coviro.2016.03.003_bib1070","series-title":"Hepatitis C Fact Sheet No. 164","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.coviro.2016.03.003_bib1075","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.03.003_bib1080","series-title":"Ebola Situation Reports","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.coviro.2016.03.003_bib1085","series-title":"Marburg Hemorrhagic Fever","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"10.1016\/j.coviro.2016.03.003_bib1090","series-title":"What You Need to Know About Lassa Fever","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.coviro.2016.03.003_bib1095","series-title":"SARS Basics Fact Sheet","author":"Centers for Disease Control and Prevention","year":"2012"},{"key":"10.1016\/j.coviro.2016.03.003_bib1100","series-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV)","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.coviro.2016.03.003_bib1105","series-title":"Chikungunya Fact Sheet No. 327","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.coviro.2016.03.003_bib1110","series-title":"Microcephaly\/Zika Virus. Latest Zika Situation Report","author":"World Health Organization","year":"2016"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716300189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716300189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T22:52:34Z","timestamp":1536879154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625716300189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":111,"alternative-id":["S1879625716300189"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2016.03.003","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccinology in the third millennium: scientific and social challenges","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}